The protein made by the SLC25A15 gene helps liver cells move ornithine into mitochondria, the cell compartments used for an important step in clearing ammonia. If it does not work well, ammonia can build up and cause a rare inherited condition called HHH syndrome. People with harmful variants may have vomiting, unusual sleepiness, confusion, trouble with learning, or liver problems, often during illness or after a high protein meal.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mainly help determine when, where, and how strongly certain processes take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. For a closer look at this topic, you can find more in LearnHub.
Overview
SLC25A15Gene function
What if the gene works
The SLC25A15 gene helps liver cells move ornithine, a natural amino acid, into a part of the cell needed for the urea cycle. This process helps clear ammonia, a waste product, from the body.
Risk
What if the gene does not work
Variants in the SLC25A15 gene can cause HHH syndrome, a urea cycle condition that may lead to high ammonia, liver problems, and learning difficulties. Milder to more severe variants can affect when symptoms begin and how strongly they appear.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the SLC25A15 gene usually direct care toward long-term ammonia control, with individualized protein restriction and citrulline or arginine supplements. Some people also need ammonia-lowering medicines such as sodium benzoate or glycerol phenylbutyrate, especially during illness or other metabolic stress. Treatment is adjusted to ammonia levels, symptoms, age, and diet tolerance.
Conditions associated with SLC25A15
Gene function
What if the gene works
Your liver cells use the SLC25A15 gene to move a small building block called ornithine into mitochondria, the parts of cells that help run key chemical steps. This movement supports the urea cycle, the main process that turns ammonia from protein breakdown into urea for removal in urine. Understanding what the SLC25A15 gene does helps explain how the body handles everyday protein waste.
Inside mitochondria, this gene’s protein acts like a gate for ornithine. It moves ornithine from the cell fluid into the mitochondria, where the next waste-handling steps take place.
By placing ornithine where it is needed, the SLC25A15 gene supports the urea cycle. This process changes ammonia, a normal waste product from protein breakdown, into urea so it can leave the body in urine.
Its protein also helps exchange ornithine and citrulline, another small molecule used in the same pathway, across the mitochondrial membrane. This back-and-forth movement keeps protein waste handling coordinated inside liver cells.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC25A15 gene can change how the cell’s ornithine transporter works inside mitochondria, the parts of cells that help manage energy and waste handling. How SLC25A15 gene variants affect protein function often comes down to reduced transport, poor folding, or failure to reach the inner mitochondrial membrane. Some variants leave partial activity, while more severe variants can abolish transport. This difference can influence how early HHH syndrome appears and how strongly it affects a person.
How variants are linked to conditions
Pathogenic variants in the SLC25A15 gene cause HHH syndrome, a rare inherited condition whose full name is hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. People with this condition may have episodes of high ammonia, liver-related problems, learning difficulties, stiffness, or coordination problems, although severity varies. In practice, variants in the SLC25A15 gene linked to HHH syndrome usually confirm the diagnosis when disease-causing changes are found in both copies of the gene.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For SLC25A15, the main risk comes from inheritance: a child is affected when they inherit a harmful change from both parents. In people living with this condition, illness, fasting, and a high-protein diet can trigger or worsen episodes of high ammonia, so risk is shaped more by the gene changes and these triggers than by general lifestyle factors.
Inheritance of SLC25A15 variants
SLC25A15-related conditions are inherited in an autosomal recessive pattern. In practical terms, how SLC25A15 gene variants are inherited usually means a child is affected only when they receive one changed copy from each parent. When both parents carry an SLC25A15 variant, each pregnancy has a 25% chance of producing an affected child, a 50% chance of producing a child who is a carrier, and a 25% chance of producing a child with two working copies. Parents of an affected child are usually healthy carriers, and brothers and sisters can inherit the same pair of variants or be carriers.
What does my SLC25A15 result mean for my family?
For families, an SLC25A15 result usually means the condition is inherited in a recessive way, so parents are often healthy carriers without symptoms. Brothers and sisters may also be affected or may be carriers, and relatives on both sides of the family could carry the same gene change. This can matter for future pregnancies and for family members who want to understand their own chance of being carriers.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the SLC25A15 gene, a lab uses a blood sample, saliva, or cheek swab for genetic testing for SLC25A15 variants. The test reads your DNA sequence and compares it with the usual gene sequence to identify changes that may help confirm HHH syndrome or show carrier status.
When should I consider getting a genetic test?
Testing for the SLC25A15 gene may be considered when someone has repeated episodes of high ammonia in the blood, vomiting, confusion, unusual sleepiness, or trouble after high-protein meals, especially starting in infancy or childhood. It can also help when a close family member has a SLC25A15 gene change or a related inherited condition.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, though how much it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better, work less well, or cause more side effects in one person than in another. These differences are common and are one reason medication response can vary even when people take the same dose. Genetics is only one part of the picture, and age, other health conditions, and other medicines also play a role.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the SLC25A15 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
SLC25A15 entered the medical literature through studies of people with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, usually shortened to HHH syndrome, first described in the late 1960s. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition helped researchers connect a rare inherited pattern to chromosome 13. In the late 1990s, variants in the SLC25A15 gene were identified as the cause of HHH syndrome in affected families. From these first observations, research expanded steadily. Over time, reports from different countries showed that this gene change can appear in many populations, while some variants were found more often in certain regions such as Quebec. These historical steps shaped today’s understanding of SLC25A15 in clinical genetics.